BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10090350)

  • 1. Hemodynamic and renal effects of indomethacin in losartan-treated hypertensive individuals.
    Olsen ME; Thomsen T; Hassager C; Ibsen H; Dige-Petersen H
    Am J Hypertens; 1999 Feb; 12(2 Pt 1):209-16. PubMed ID: 10090350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Add-on angiotensin receptor blockade with maximized ACE inhibition.
    Agarwal R
    Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic angiotensin II antagonism with losartan in one-kidney, one clip hypertensive rats: effect on cardiac hypertrophy, urinary sodium and water excretion and the natriuretic system.
    Garcia R; Bonhomme MC; Diebold S
    J Hypertens; 1996 Jan; 14(1):81-9. PubMed ID: 12013499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
    Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal effects of urodilatin in healthy subjects are independent of blockade of the cyclooxygenase and angiotensin II receptor.
    Carstens J; Pedersen EB
    Scand J Clin Lab Invest; 2008; 68(1):2-10. PubMed ID: 17852806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal effects of losartan and amlodipine in hypertensive patients with non-diabetic nephropathy.
    Holdaas H; Hartmann A; Berg KJ; Lund K; Fauchald P
    Nephrol Dial Transplant; 1998 Dec; 13(12):3096-102. PubMed ID: 9870472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension.
    Fagard R; Lijnen P; Pardaens K; Thijs L; Vinck W
    J Hum Hypertens; 2001 Mar; 15(3):161-7. PubMed ID: 11317199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.
    Lacourcière Y; Asmar R
    Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
    Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
    J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparate systemic and renal blocking properties of angiotensin II antagonists during exogenous angiotensin II administration: implications for treatment.
    Willemsen JM; Rabelink TJ; Boer P; Gaillard CA
    J Hum Hypertens; 2004 Dec; 18(12):857-63. PubMed ID: 15361886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A low-sodium diet potentiates the effects of losartan in type 2 diabetes.
    Houlihan CA; Allen TJ; Baxter AL; Panangiotopoulos S; Casley DJ; Cooper ME; Jerums G
    Diabetes Care; 2002 Apr; 25(4):663-71. PubMed ID: 11919122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: results from the randomized, double-blind, crossover GENRES Study.
    Suonsyrjä T; Hannila-Handelberg T; Paavonen KJ; Miettinen HE; Donner K; Strandberg T; Tikkanen I; Tilvis R; Pentikäinen PJ; Kontula K; Hiltunen TP
    J Hypertens; 2008 Jun; 26(6):1250-6. PubMed ID: 18475165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of chronic ACE inhibition and AT1 receptor blocked losartan on cardiac hypertrophy and renal function in hypertensive patients.
    De Rosa ML; Cardace P; Rossi M; Baiano A; de Cristofaro A
    J Hum Hypertens; 2002 Feb; 16(2):133-40. PubMed ID: 11850771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypotensive effect of losartan, a nonpeptide angiotensin II receptor antagonist, in essential hypertension.
    Tsunoda K; Abe K; Hagino T; Omata K; Misawa S; Imai Y; Yoshinaga K
    Am J Hypertens; 1993 Jan; 6(1):28-32. PubMed ID: 8427658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of indomethacin on blood pressure lowering by captopril and losartan in hypertensive patients.
    Conlin PR; Moore TJ; Swartz SL; Barr E; Gazdick L; Fletcher C; DeLucca P; Demopoulos L
    Hypertension; 2000 Sep; 36(3):461-5. PubMed ID: 10988282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.
    Waanders F; Vaidya VS; van Goor H; Leuvenink H; Damman K; Hamming I; Bonventre JV; Vogt L; Navis G
    Am J Kidney Dis; 2009 Jan; 53(1):16-25. PubMed ID: 18823687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of long-term losartan and L-arginine treatment on haemodynamics, glomerular filtration, and SOD activity in spontaneously hypertensive rats.
    Miloradović Z; Jovović D; Mihailović-Stanojević N; Milanović JG; Milanović S
    Can J Physiol Pharmacol; 2008 Apr; 86(4):210-4. PubMed ID: 18418431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP2C9 genotype modifies activity of the renin-angiotensin-aldosterone system in hypertensive men.
    Donner KM; Hiltunen TP; Suonsyrjä T; Hannila-Handelberg T; Tikkanen I; Antikainen M; Hirvonen A; Kontula K
    J Hypertens; 2009 Oct; 27(10):2001-9. PubMed ID: 19593208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection.
    Peng F; Lin J; Lin L; Tang H
    Int J Mol Med; 2012 Dec; 30(6):1376-86. PubMed ID: 23064712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of angiotensin II receptor antagonist on autoregulation of zonal glomerular filtration rate in renovascular hypertensive rats.
    Wang X; Aukland K; Iversen BM
    Kidney Blood Press Res; 1997; 20(4):225-32. PubMed ID: 9398027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.